News | February 15, 2021
Glenmark Q3 FY21 net profit up 30% at Rs 248 Cr
The jump in profit is due to the better performance of the API business.
The jump in profit is due to the better performance of the API business.
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
The company is expecting tremendous growth and a better quarterly performance
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
Subscribe To Our Newsletter & Stay Updated
